Alopecia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Alopecia}} | {{Alopecia}} | ||
{{CMG}}; {{AE}} [[Ogechukwu Hannah Nnabude, MD]] | |||
==Overview== | |||
The epidemiology and demographics of alopecia varies by age, race, sex, and health status. | |||
==Alopecia epidemiology and demographics== | |||
* Androgenetic alopecia affects 50% of men and 15% of women, particularly postmenopausal women. <ref name="pmid30513014">{{cite journal| author=Rinaldi F, Marzani B, Pinto D, Sorbellini E| title=Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata. | journal=J Dermatolog Treat | year= 2019 | volume= 30 | issue= 6 | pages= 588-593 | pmid=30513014 | doi=10.1080/09546634.2018.1544405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30513014 }} </ref> | |||
* In alopecia areata, the prevalence is 0.2% and has no age or sexual predilection. However, it affects white races more than dark races. | |||
* In telogen effluvium, women are at higher predisposition than men. | |||
* Tinea capitis has a higher incidence among the pediatric age group and in darker races. <ref name="pmid30511475">Owczarczyk-Saczonek A, Wygonowska E, Budkiewicz M, Placek W (2019) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=30511475 Serum sickness disease in a patient with alopecia areata and Meniere' disease after PRP procedure.] ''Dermatol Ther'' 32 (2):e12798. [http://dx.doi.org/10.1111/dth.12798 DOI:10.1111/dth.12798] PMID: [https://pubmed.gov/30511475 30511475]</ref> | |||
* Anagen effluvium is more common in cancer patients receiving treatment with chemotherapeutic agents. | |||
==References== | ==References== | ||
Revision as of 09:41, 12 December 2020
|
Alopecia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alopecia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Alopecia epidemiology and demographics |
|
Risk calculators and risk factors for Alopecia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogechukwu Hannah Nnabude, MD
Overview
The epidemiology and demographics of alopecia varies by age, race, sex, and health status.
Alopecia epidemiology and demographics
- Androgenetic alopecia affects 50% of men and 15% of women, particularly postmenopausal women. [1]
- In alopecia areata, the prevalence is 0.2% and has no age or sexual predilection. However, it affects white races more than dark races.
- In telogen effluvium, women are at higher predisposition than men.
- Tinea capitis has a higher incidence among the pediatric age group and in darker races. [2]
- Anagen effluvium is more common in cancer patients receiving treatment with chemotherapeutic agents.
References
- ↑ Rinaldi F, Marzani B, Pinto D, Sorbellini E (2019). "Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata". J Dermatolog Treat. 30 (6): 588–593. doi:10.1080/09546634.2018.1544405. PMID 30513014.
- ↑ Owczarczyk-Saczonek A, Wygonowska E, Budkiewicz M, Placek W (2019) Serum sickness disease in a patient with alopecia areata and Meniere' disease after PRP procedure. Dermatol Ther 32 (2):e12798. DOI:10.1111/dth.12798 PMID: 30511475